PAVmed Inc (PAVM)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

Form 8-K - Current report

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results

PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire NEW YORK, May...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results

Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire NEW...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form DEF 14A - Other definitive proxy statements

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026

PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 PR Newswire...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Form ARS - Annual Report to Security Holders

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026

Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 PR...

Form EFFECT - Notice of Effectiveness

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock

Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock PR Newswire NEW...

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock

Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock PR Newswire NEW YORK, April...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]